Skip to main content

Advertisement

SpringerLink
Log in

Prognostic Value of Stress Myocardial Perfusion Imaging in Asymptomatic Diabetic Patients

  • Cardiac Nuclear Imaging (A Cuocolo, Section Editor)
  • Published:
Current Cardiovascular Imaging Reports Aims and scope Submit manuscript

Abstract

Although there has been a marked decline in mortality due to coronary artery disease (CAD) in the overall population in the past three decades, reducing CAD mortality in patients with diabetes has proven exceptionally difficult. Several epidemiological studies have shown that diabetes is associated with a marked increase in the risk of CAD. The symptoms are not a reliable means of identifying patients at higher risk considering that angina is threefold less common in diabetics than in nondiabetics. The increasing prevalence of diabetes and the associated high cardiac risk raised the question as to the need to develop approaches to identify the diabetic patients at the highest risk of CAD. Stress myocardial perfusion single-photon emission computed tomography has taken a central role in the diagnosis, evaluation, and management of CAD in diabetic patients. This review focuses on the prognostic value of cardiac radionuclide imaging in asymptomatic diabetic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary artery disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–34.

    Article  CAS  PubMed  Google Scholar 

  2. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes. Diabetes Care. 1999;22:1396–400.

    Article  CAS  PubMed  Google Scholar 

  3. May O, Arildsen H, Damsgaard EM, Mickley H. Prevalence and prediction of silent ischemia in diabetes mellitus: a population-based study. Cardiovasc Res. 1997;34:241–7.

    Article  CAS  PubMed  Google Scholar 

  4. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107:2900–7.

    Article  PubMed  Google Scholar 

  5. International Diabetes Federation. Diabetes e-Atlas. Brussels: International Diabetes Federation. 2014. http://www.idf.org/diabetesatlas/.

  6. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291–7.

    Article  CAS  PubMed  Google Scholar 

  7. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434–44.

    Article  CAS  PubMed  Google Scholar 

  8. Goraya TY, Leibson CL, Palumbo PJ, et al. Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol. 2002;40:946–53.

    Article  PubMed  Google Scholar 

  9. Donnan PT, Boyle DI, Broomhall J, et al. Prognosis following first acute myocardial infarction in type 2 diabetes: a comparative population study. Diabet Med. 2002;19:448–55.

    Article  CAS  PubMed  Google Scholar 

  10. Burke AP, Kolodgie FD, Zieske A, et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol. 2004;24:1266–71.

    Article  CAS  PubMed  Google Scholar 

  11. Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart. Circulation. 1995;92:2333–42.

    Article  CAS  PubMed  Google Scholar 

  12. Miller TD, Rajagopalan N, Hodge DO, Frye RL, Gibbons RJ. Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J. 2004;147:890–6.

    Article  PubMed  Google Scholar 

  13. Cohn PF, Fox KM, Daly C. Silent myocardial ischemia. Circulation. 2003;108:1263–77.

    Article  PubMed  Google Scholar 

  14. Grundy SM, Cleeman JI, Merz CN, National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227–39.

    Article  PubMed  Google Scholar 

  15. Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am Heart J. 1985;110:1100–7.

    Article  CAS  PubMed  Google Scholar 

  16. McPhillips JB, Barrett-Connor E, Wingard DL. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol. 1990;131:443–53.

    CAS  PubMed  Google Scholar 

  17. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134–46.

    Article  CAS  PubMed  Google Scholar 

  18. Petretta M, Acampa W, Fiumara G, Cuocolo A. Cardiovascular risk stratification in diabetic patients. Clin Transl Imaging. 2013;1:325–39.

    Google Scholar 

  19. Evans JM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ. 2002;324:939–42.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Lee CD, Folsom AR, Pankow JS, Brancati FL, Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 2004;109:855–60.

    Article  PubMed  Google Scholar 

  21. Acampa W, Petretta M, Evangelista L, et al. Myocardial perfusion imaging and risk classification for coronary heart disease in diabetic patients. The IDIS study: a prospective, multicentre trial. Eur J Nucl Med Mol Imaging. 2012;39:387–95.

    Article  PubMed  Google Scholar 

  22. Bax JJ, Bonow RO, Tschöpe D, Inzucchi SE, Barrett E, Global Dialogue Group for the Evaluation of Cardiovascular Risk in Patients With Diabetes. The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes. J Am Coll Cardiol. 2006;48:754–60.

    Article  PubMed  Google Scholar 

  23. Miller TD, Redberg RF, Wackers FJ. Screening asymptomatic diabetic patients for coronary artery disease: why not? J Am Coll Cardiol. 2006;48:761–4.

    Article  PubMed  Google Scholar 

  24. Miller TD, Shaw LJ. Risk stratification in diabetic patients: a continuing challenge. J Nucl Cardiol. 2009;16:486–9.

    Article  PubMed  Google Scholar 

  25. Kothari V, Stevens RJ, Adler AI, et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke. 2002;33:1776–81.

    Article  PubMed  Google Scholar 

  26. Stevens RJ, Kothari V, Adler AI, Stratton IM, United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond). 2001;101:671–9.

    Article  CAS  Google Scholar 

  27. American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care. 1998;21:1551–9.

    Article  Google Scholar 

  28. Wackers FJ, Young LH, Inzucchi SE, et al. Detection of Ischemia in Asymptomatic Diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27:1954–61.

    Article  PubMed  Google Scholar 

  29. Wackers FJ, Zaret BL. Detection of myocardial ischemia in patients with diabetes mellitus. Circulation. 2002;105:5–7.

    PubMed  Google Scholar 

  30. Rajagopalan N, Miller TD, Hodge DO, Frye RL, Gibbons RJ. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol. 2005;45:43–9.

    Article  PubMed  Google Scholar 

  31. Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2006;47:65–71.

    Article  PubMed  Google Scholar 

  32. Torremocha F, Hadjadj S, Carrié F, Rosenberg T, Herpin D, Maréchaud R. Prediction of major coronary events by coronary risk profile and silent myocardial ischaemia: prospective follow-up study of primary prevention in 72 diabetic patients. Diabetes Metab. 2001;27:49–57.

    CAS  PubMed  Google Scholar 

  33. Le Feuvre CL, Barthélémy O, Dubois-Laforgue D, et al. Stress myocardial scintigraphy and dobutamine echocardiography in the detection of coronary disease in asymptomatic patients with type 2 diabetes. Diabetes Metab. 2005;31:135–42.

    Article  PubMed  Google Scholar 

  34. Senior PA, Welsh RC, McDonald CG, Paty BW, Shapiro AM, Ryan EA. Coronary artery disease is common in nonuremic, asymptomatic type 1 diabetic islet transplant candidates. Diabetes Care. 2005;28:866–72.

    Article  PubMed  Google Scholar 

  35. Zellweger MJ, Hachamovitch R, Kang X, et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J. 2004;25:543–50.

    Article  PubMed  Google Scholar 

  36. Young LH, Wackers FJ, Chyun DA, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with diabetes type 2: the DIAD study: a randomized controlled trial. JAMA. 2009;301:1547–55.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.

    Article  Google Scholar 

  38. Bhatt DL, Eagle KA, Ohman EM, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA. 2010;304:1350–7.

    Article  CAS  PubMed  Google Scholar 

  39. Bansal S, Wackers FJ, Inzucchi SE, et al. Five-year outcomes in high-risk participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study: a post hoc analysis. Diabetes Care. 2011;34:204–9.

    Article  PubMed Central  PubMed  Google Scholar 

  40. Valensi P, Cosson E. It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia. Diabetes Metab. 2010;36:91–6.

    Article  CAS  PubMed  Google Scholar 

  41. Shah PK. Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we? J Am Coll Cardiol. 2010;56:98–105.

    Article  PubMed  Google Scholar 

  42. Upchurch CT, Barrett EJ. Screening for coronary artery disease in type 2 diabetes. J Clin Endocrinol Metab. 2012;97:1434–42.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Greenland P, Alpert JS, Beller GA, American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010;122:e584–636.

    Article  PubMed  Google Scholar 

  44. Berman DS, Kang X, Hayes SW, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol. 2003;41:1125–33.

    Article  PubMed  Google Scholar 

  45. De Lorenzo A, Lima RS, Siqueira-Filho AG, Pantoja MR. Prevalence and prognostic value of perfusion defects detected by stress technetium-99 m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol. 2002;90:827–32.

    Article  PubMed  Google Scholar 

  46. Valensi P, Pariès J, Brulport-Cerisier V, et al. Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study. Diabetes Care. 2005;28:2722–7.

    Article  PubMed  Google Scholar 

  47. Faglia E, Favales F, Calia P, Milan Study on Atherosclerosis and Diabetes (MiSAD), et al. Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care. 2002;25:2032–6.

    Article  PubMed  Google Scholar 

  48. Bourque JM, Patel CA, Ali MM, Perez M, Watson DD, Beller GA. Prevalence and predictors of ischemia and outcomes in outpatients with diabetes mellitus referred for single-photon emission computed tomography myocardial perfusion imaging. Circ Cardiovasc Imaging. 2013;6:466–77.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Petretta M, Cuocolo A. Prediction models for risk classification in cardiovascular disease. Eur J Nucl Med Mol Imaging. 2012;39:1959–69. Different prediction models to be used for risk stratification.

    Article  PubMed  Google Scholar 

  50. Petretta M, Acampa W, Evangelista L, et al. (2013) Reclassification of cardiovascular risk by myocardial perfusion imaging in diabetic patients with abnormal resting electrocardiogram. Nutr Metab Cardiovasc Dis. doi:10.1016/j.numecd.2013.11.009

  51. Acampa W, Petretta M, Daniele S, et al. Incremental prognostic value of stress myocardial perfusion imaging in asymptomatic diabetic patients. Atherosclerosis. 2013;227:307–12.

    Article  CAS  PubMed  Google Scholar 

  52. Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol. 2003;41:1329–40.

    Article  PubMed  Google Scholar 

  53. Acampa W, Petretta M, Cuocolo R, Daniele S, Cantoni V, Cuocolo A. Warranty period of normal stress myocardial perfusion imaging in diabetic patients: a propensity score analysis. J Nucl Cardiol. 2014;21:50–6. New data regarding the warranty period in diabetic patients.

    Article  PubMed  Google Scholar 

  54. Berry C, Tardif JC, Bourassa MG. Coronary heart disease in patients with diabetes. Part I: recent advances in prevention and noninvasive management. J Am Coll Cardiol. 2007;49:631–42.

    Article  CAS  PubMed  Google Scholar 

  55. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. J Am Med Assoc. 2002;287:2570–81.

    Article  CAS  Google Scholar 

  56. Navare SM, Katten D, Johnson LL, et al. Risk stratification with electrocardiographic-gated dobutamine stress technetium-99 m sestamibi single-photon emission tomographic imaging. Value of heart rate response and assessment of left ventricular function. J Am Coll Cardiol. 2006;47:781–8.

    Article  PubMed  Google Scholar 

  57. Petretta M, Acampa W, Daniele S, et al. Transient ischemic dilation in SPECT myocardial perfusion imaging for prediction of severe coronary artery disease in diabetic patients. J Nucl Cardiol. 2013;20:45–52.

    Article  PubMed  Google Scholar 

  58. Petretta M, Acampa W, Daniele S, Petretta MP, Plaitano M, Cuocolo A. Transient ischemic dilation in patients with diabetes mellitus: prognostic value and effect on clinical outcome after coronary revascularization. Circ Cardiovasc Imaging. 2013;6:908–15.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

Wanda Acampa, Valeria Cantoni, Roberta Green, Renato Cuocolo, Maria Piera Petretta, Massimiliano Orlandi, and Mario Petretta declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Institute of Biostructure and Bioimaging, National Council of Research, Naples, Italy

    Wanda Acampa

  2. SDN Foundation, Institute of Diagnostic and Nuclear Development, Naples, Italy

    Valeria Cantoni

  3. Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy

    Roberta Green, Renato Cuocolo, Maria Piera Petretta & Massimiliano Orlandi

  4. Department of Translational Medicine, University Federico II, Naples, Italy

    Mario Petretta

Authors
  1. Wanda Acampa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Valeria Cantoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roberta Green
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Renato Cuocolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria Piera Petretta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Massimiliano Orlandi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mario Petretta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wanda Acampa.

Additional information

This article is part of the Topical Collection on Cardiac Nuclear Imaging

Rights and permissions

Reprints and permissions

About this article

Cite this article

Acampa, W., Cantoni, V., Green, R. et al. Prognostic Value of Stress Myocardial Perfusion Imaging in Asymptomatic Diabetic Patients. Curr Cardiovasc Imaging Rep 7, 9268 (2014). https://doi.org/10.1007/s12410-014-9268-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s12410-014-9268-y

Keywords

Search

Navigation